Telligent Fund LP lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 11.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,000 shares of the medical equipment provider’s stock after buying an additional 400 shares during the period. Intuitive Surgical makes up about 2.0% of Telligent Fund LP’s investment portfolio, making the stock its 26th largest holding. Telligent Fund LP’s holdings in Intuitive Surgical were worth $2,174,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Tobam grew its stake in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares in the last quarter. 1248 Management LLC acquired a new stake in Intuitive Surgical in the first quarter worth about $30,000. Princeton Global Asset Management LLC bought a new position in Intuitive Surgical in the 2nd quarter valued at about $30,000. Finally, Bank of Jackson Hole Trust increased its stake in Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 31 shares during the period. 83.64% of the stock is owned by institutional investors.
Intuitive Surgical Stock Up 3.3%
ISRG opened at $564.64 on Thursday. The firm has a market cap of $202.41 billion, a PE ratio of 74.69, a P/E/G ratio of 4.94 and a beta of 1.62. The business has a fifty day simple moving average of $487.92 and a 200-day simple moving average of $503.76. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.
Insider Activity
In other news, VP Fredrik Widman sold 2,067 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the sale, the vice president owned 473 shares in the company, valued at $260,150. The trade was a 81.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the sale, the executive vice president owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 116,164 shares of company stock worth $61,916,172. 0.70% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on ISRG shares. The Goldman Sachs Group raised their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. BTIG Research increased their price target on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. Finally, Piper Sandler raised their target price on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $608.92.
View Our Latest Analysis on ISRG
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Business Services Stocks Investing
- Is Tesla Setting Up for a Year-End Rebound—or a Collapse?
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Applied Materials: Up 40% in 2025 With Room to Run Long-Term
- How to Profit From Value Investing
- onsemi Places a $6 Billion Bet on Its Own Stock
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
